$1.17 Trillion is the total value of WestEnd Advisors, LLC's 35 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 9.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PYPL | Sell | PayPal Holdings, Inc. | $63,908,840,000 | +12.9% | 1,190,774 | -9.5% | 5.47% | +15.6% |
| UNH | Sell | UnitedHealth Group, Inc. | $56,987,353,000 | +3.8% | 307,342 | -8.1% | 4.87% | +6.3% |
| MDT | Sell | Medtronic Inc. | $56,297,231,000 | +1.6% | 634,335 | -7.8% | 4.82% | +4.0% |
| MA | Sell | Mastercard Inc. | $55,988,692,000 | -1.1% | 461,002 | -8.4% | 4.79% | +1.3% |
| ADBE | Sell | Adobe Systems, Inc. | $55,754,799,000 | -4.1% | 394,194 | -11.8% | 4.77% | -1.8% |
| GOOGL | Sell | Alphabet Inc. Class A | $55,636,699,000 | +0.3% | 59,845 | -8.6% | 4.76% | +2.7% |
| MSFT | Sell | Microsoft Corp | $55,121,804,000 | -3.9% | 799,678 | -8.2% | 4.72% | -1.7% |
| SBUX | Sell | Starbucks Corp | $53,850,626,000 | -7.7% | 923,523 | -7.6% | 4.61% | -5.5% |
| CELG | Sell | Celgene Corp. | $53,817,218,000 | -3.4% | 414,393 | -7.4% | 4.60% | -1.1% |
| GILD | Sell | Gilead Sciences, Inc. | $53,471,812,000 | -3.5% | 755,465 | -7.4% | 4.57% | -1.2% |
| AAPL | Sell | Apple, Inc. | $53,252,115,000 | -7.8% | 369,755 | -8.0% | 4.56% | -5.6% |
| AGN | Sell | Allergan plc | $53,230,632,000 | -6.0% | 218,975 | -7.6% | 4.55% | -3.7% |
| JPM | Sell | JPMorgan Chase & Co. | $53,143,798,000 | -2.9% | 581,442 | -6.7% | 4.55% | -0.6% |
| BMY | Sell | Bristol-Myers Squibb | $51,631,322,000 | -4.7% | 926,621 | -7.0% | 4.42% | -2.5% |
| BIIB | Sell | Biogen, Inc. | $51,457,996,000 | -8.1% | 189,630 | -7.4% | 4.40% | -5.9% |
| DIS | Sell | Disney, Walt Co. | $49,703,643,000 | -12.6% | 467,799 | -6.7% | 4.25% | -10.5% |
| TJX | Sell | TJX Companies | $48,735,967,000 | -14.5% | 675,294 | -6.3% | 4.17% | -12.5% |
| KHC | Sell | Kraft Heinz Co. | $48,581,516,000 | -12.3% | 567,276 | -7.0% | 4.16% | -10.2% |
| KR | Sell | Kroger Company | $41,850,841,000 | -25.7% | 1,794,633 | -6.1% | 3.58% | -24.0% |
| BIVV | Exit | BIOVERATIV INC | $0 | – | -10 | -100.0% | 0.00% | – |
| BSV | Exit | VANGUARD SHORT TERM BND | $0 | – | -124 | -100.0% | -0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INTL EQUITY INDEX F A | 38 | Q3 2023 | 9.0% |
| SELECT SECTOR SPDR TR SBI HEAL | 38 | Q3 2023 | 13.8% |
| SELECT SECTOR SPDR TR SBI CONS | 38 | Q3 2023 | 6.5% |
| SELECT SECTOR SPDR TR SBI CONS | 38 | Q3 2023 | 6.7% |
| APPLE INC COM | 36 | Q3 2023 | 5.2% |
| TJX COS INC NEW | 36 | Q3 2023 | 5.7% |
| ISHARES TR RUSSELL 3000 | 36 | Q4 2022 | 0.0% |
| DISNEY WALT CO | 33 | Q3 2023 | 5.4% |
| iShares iBoxx $ Invest. Grade Corp Bd ETF | 33 | Q4 2021 | 2.6% |
| SPDR TR UNIT SER 1 | 33 | Q3 2023 | 3.5% |
View WestEnd Advisors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-07 |
| 13F-HR | 2024-01-18 |
| 13F-HR | 2023-10-19 |
| 13F-HR | 2023-07-21 |
| 13F-HR | 2023-04-28 |
| 13F-HR | 2023-01-31 |
| 13F-HR | 2022-10-27 |
| 13F-HR | 2022-07-28 |
| 13F-HR | 2022-04-26 |
| 13F-HR | 2022-01-14 |
View WestEnd Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.